CHICAGO, IL, March 10, 2026 /24-7PressRelease/ -- Indranil Roy has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Roy has established himself as a pioneering figure at the intersection of artificial intelligence and health care technology. As the Founder and Chief Executive Officer of Telerapp since 2021, he has led the company with a leadership philosophy centered on disciplined innovation. Drawing from his scientific background, he emphasizes the importance of combining visionary thinking with structured execution. He is dedicated to empowering his team to innovate boldly while maintaining clinical rigor, data integrity and operational reliability—qualities he considers non-negotiable in health care technology and services.

Under Dr. Roy's guidance, Telerapp has scaled its operations globally, supporting continued growth and operational efficiency. He is actively involved in attending meetings and reviewing global operations to ensure that the company's technologies and services are meticulously designed, validated and delivered with precision. Through these efforts, Dr. Roy and his team have made significant contributions to the field, impacting approximately 2.5 million lives annually through their advanced solutions and services.

Prior to founding Telerapp, Dr. Roy served as a postdoctoral researcher in Nobel Laureate Sir Fraser Stoddart's research group at Northwestern University in Chicago from 2017 to 2022. During this period, he conducted advanced research in supramolecular chemistry, molecular machines, photophysics, theranostics, and applied machine learning while collaborating across interdisciplinary teams. His research heightened his awareness of systemic challenges in health care—particularly diagnostic errors and the impact of misdiagnosis on a global scale. This experience inspired him to leverage technology as a means to address these critical gaps, ultimately leading to the creation of Telerapp's platform, which merges artificial intelligence innovation with clinical excellence.

Today, Dr. Roy is recognized for his expertise in augmenting diagnostic intelligence, artificial intelligence–powered quantum radiology operating systems, intelligent workflow orchestration, and advanced dictation tools designed to optimize the click economy and enhance productivity. His achievements include securing several patents throughout his career, reflecting his commitment to advancing technology in meaningful ways.

Dr. Roy's academic journey began with a master's degree in chemistry from the Indian Institute of Technology Kanpur in India, completed in 2010. He subsequently earned a Doctor of Philosophy in supramolecular chemistry from Pohang University of Science and Technology in South Korea in 2016 under the supervision of Professor Kimoon Kim. He has further strengthened his professional engagement through membership in the Radiological Society of North America and the American Chemical Society. Overall, he attributes his success to global exposure, hard work, dedication, and thorough research, guided by the belief that necessity drives invention and that every innovation should be grounded in logic with a clear purpose for improvement.

Dr. Roy's commitment extends beyond professional achievements to civic engagement as a supporter and contributor to affordable health care services in India, Africa, and SAARC countries, with a focus on developing nations. Outside his professional pursuits, he enjoys painting, photography, playing cricket, and exploring new places.

In addition to his material advancements, Dr. Roy has also made substantial contributions to scientific literature as the author of over 25 published peer-reviewed papers and as a peer reviewer for various international journals. Looking ahead in his profession, he is focused on enhancing diagnostic intelligence by integrating innovative technologies into Telerapp's platform—including the development of a health care-specific data center designed to protect data and ensure compliance—with the overarching goal of providing proper care to patients through the responsible management of health care data.

Dr. Roy also highlights the powerful role that individuals from academic and scientific backgrounds can play in the business sector. He underscores that the analytical rigor, problem-solving capabilities, and innovative thinking cultivated through research and university experience translate seamlessly into corporate leadership and entrepreneurial success. Drawing from his own journey, he illustrates how a career rooted in science can evolve into impactful business ventures, encouraging fellow scientists to bring laboratory innovations and emerging technologies into the marketplace to expand their real-world impact. He further emphasizes the importance of aligning artificial intelligence with human expertise, advocating for a synergistic approach that drives sustainable growth and meaningful advancement.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #